Prognostic scores for patients with chronic myeloid leukemia under particular consideration of competing causes of death.

Prognostic scores for patients with chronic myeloid leukemia under particular consideration of competing causes of death.

Item
http://www.wikidata.org/entity/Q38392698
Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.Insights into the management of chronic myeloid leukemia in resource-poor settings: a Mexican perspective.No influence of BCR-ABL1 transcript types e13a2 and e14a2 on long-term survival: results in 1494 patients with chronic myeloid leukemia treated with imatinib.PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase.Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.MicroRNA-181 as a prognostic biomarker for survival in acute myeloid leukemia: a meta-analysis.The underestimated role of basophils in Ph chronic myeloid leukaemia
P2860

Prognostic scores for patients with chronic myeloid leukemia under particular consideration of competing causes of death.

Item
http://www.wikidata.org/entity/Q38392698
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prognostic scores for patients ...... of competing causes of death.
@en
type
label
Prognostic scores for patients ...... of competing causes of death.
@en
prefLabel
Prognostic scores for patients ...... of competing causes of death.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P50
P577
P698
P921
P356
P1433
P1476
Prognostic scores for patients ...... n of competing causes of death
@en
P2093
P2860
P304
P31
P356
P478
P50
P577
P698
P921